DoxyPEP Use Rises Across Europe
New research estimates doxycycline post-exposure prophylaxis accounts for millions of daily doses in Europe.
Updated on Oct. 30, 2026 in Sex Life
Live Poll
Do you trust that preventative antibiotic use is worth the risk of increasing antimicrobial resistance?
Researchers estimate that annual doxyPEP use accounts for 4.4 million defined daily doses of doxycycline across Europe. This usage represents a 1.9% increase in total regional doxycycline consumption compared to 2023 levels.
Why it matters
Understanding the scale of doxyPEP usage is critical for public health officials monitoring the impact of prophylactic antibiotic use on STI rates and the development of antibiotic resistance. The findings provide clarity on the prevalence of this practice among PrEP users.
Estimates indicate that 33% of European PrEP users utilize doxyPEP, with the average user taking 24 courses per year. Each standard doxyPEP course consists of a single 200 mg dose of the antibiotic.
The details
To reach these figures, researchers ran a Monte Carlo simulation 10,000 times, incorporating variables such as the total number of PrEP users and the frequency of individual doxyPEP usage. The study also calculated that the use of these prophylactics avoids roughly 326,151 defined daily doses that would otherwise be required to treat chlamydia infections.
Timeline
2023 served as the baseline year for total doxycycline consumption levels.
Chlamydia and syphilis rates have increased in Europe over the past ten years.
Culture Shift
This trend mirrors the ongoing response to the rise of syphilis and chlamydia rates in Europe over the last decade. The widespread adoption of doxyPEP marks a significant shift in how the sexual health community integrates prophylactic antibiotic use into daily life.
The adoption of doxyPEP requires users to manage specific dosage schedules, typically involving a single 200 mg dose after potential exposure. Individuals should consult with their healthcare providers to determine if this preventive approach aligns with their personal health needs.
The takeaway
DoxyPEP usage is now a measurable component of antibiotic consumption in Europe. Tracking this practice is essential for balancing the prevention of STIs with the broader goals of antibiotic stewardship.
Further reading
For more on evolving sexual health trends, see the Sex Life section.
Source note: This article includes information reported by Aidsmap.
Live Poll
Do you trust that preventative antibiotic use is worth the risk of increasing antimicrobial resistance?
